This brand name is authorized in Canada, United States
The drug YF-VAX contains one active pharmaceutical ingredient (API):
|
1
Yellow fever, live attenuated
UNII PY4EET359T - YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| YF-VAX Powder for suspension | FDA, National Drug Code (US) | MPI, US: SPL/Old |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07BL01 | Yellow fever, live attenuated | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BL Yellow fever vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 00428833 |
| Country: US | FDA, National Drug Code | Identifier(s): 49281-915 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
